What Is the KLOW blend?
Last reviewed:
KLOW is Lazarus Labs’ 80 mg research blend: four peptides supplied together in one lyophilised vial — GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg). Each component has its own citation-backed overview; this page explains what the blend contains and how it is tested. Evidence for the components is preclinical.
What is in the KLOW blend?
One KLOW vial contains 80 mg of peptide material: 50 mg of the copper-binding tripeptide GHK-Cu, 10 mg of the pentadecapeptide BPC-157, 10 mg of TB-500 (thymosin beta-4) and 10 mg of the tripeptide KPV.
How are the KLOW components classified?
The four components come from different peptide families: GHK-Cu is a naturally occurring copper-complexing tripeptide, BPC-157 is a synthetic gastric-pentadecapeptide fragment, TB-500 corresponds to the actin-binding beta-thymosin family, and KPV is the C-terminal tripeptide of alpha-MSH. The blend groups them for laboratory convenience; it does not create a new molecule.
What research exists on the KLOW components?
Each component carries its own primary literature: BPC-157’s preclinical tissue-model record, GHK-Cu’s copper-biology and gene-expression research, Tβ4’s actin-sequestration biochemistry and KPV’s PepT1-transport and inflammatory-signalling studies. The component overviews list and link the key papers individually.
There is no published literature on the four compounds combined; the blend’s evidence base is its components’.
What compounds is KLOW studied alongside?
The components appear in the tissue-repair and copper-peptide research fields, so the blend is most naturally compared with its own constituents studied singly, and with the categories they belong to: Tissue-Repair Research Peptides and Copper Peptides.
How is KLOW supplied, tested and handled?
KLOW 80MG is supplied as a single lyophilised vial with third-party batch documentation and a Certificate of Analysis covering the blend. Store cold, dry and protected from light in accordance with your laboratory protocol.
References
- Sikiric P, Hahm KB, Blagaic AB, et al. Gut and Liver. 2020. PMID: 31158953.
- Pickart L, Margolina A International Journal of Molecular Sciences. 2018. PMID: 29986520.
- Weber A, Nachmias VT, Pennise CR, et al. Biochemistry. 1992. PMID: 1627561.
- Dalmasso G, et al. Gastroenterology. 2008. PMID: 18061177.
Primary literature, verified against PubMed. Citations are provided for scientific reference and do not imply a human-use indication.
Important
For research use only. Not for human or veterinary consumption. KLOW is supplied solely as a laboratory reference material. Lazarus Labs makes no therapeutic, medical or performance claims, and nothing on this page is medical advice.